QLOSI Trademark

Trademark Overview

On Thursday, September 15, 2022, a trademark application was filed for QLOSI with the United States Patent and Trademark Office. The USPTO has given the QLOSI trademark a serial number of 97592402. The federal status of this trademark filing is REGISTERED as of Tuesday, February 17, 2026. This trademark is owned by Orasis Pharmaceuticals Ltd.. The QLOSI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of eye disorders and diseases
qlosi

General Information

Serial Number97592402
Word MarkQLOSI
Filing DateThursday, September 15, 2022
Status700 - REGISTERED
Status DateTuesday, February 17, 2026
Registration Number8145782
Registration DateTuesday, February 17, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 8, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of eye disorders and diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 29, 2022
Primary Code005
First Use Anywhere DateTuesday, April 1, 2025
First Use In Commerce DateTuesday, April 1, 2025

Trademark Owner History

Party NameOrasis Pharmaceuticals Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressHerzliya 4673328
IL
Party NameOrasis Pharmaceuticals Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressHerzliya 4673328
IL
Party NameOrasis Pharmaceuticals Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHerzliya 4673328
IL

Trademark Events

Event DateEvent Description
Monday, September 19, 2022NEW APPLICATION ENTERED
Thursday, September 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 27, 2023ASSIGNED TO EXAMINER
Sunday, July 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 8, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 8, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 12, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 12, 2024SOU EXTENSION 1 FILED
Tuesday, March 12, 2024SOU EXTENSION 1 GRANTED
Wednesday, March 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 1, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 1, 2024SOU EXTENSION 2 FILED
Tuesday, October 1, 2024SOU EXTENSION 2 GRANTED
Tuesday, October 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 29, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, January 29, 2025SOU EXTENSION 3 FILED
Wednesday, January 29, 2025SOU EXTENSION 3 GRANTED
Tuesday, March 4, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 21, 2025TEAS STATEMENT OF USE RECEIVED
Sunday, January 18, 2026ASSIGNED TO EXAMINER
Saturday, January 24, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 21, 2025USE AMENDMENT FILED
Monday, January 26, 2026STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 27, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 27, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 17, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, February 17, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

qlosi diseases disorders treatment preparations pharmaceutical